Adult Rheumatoid Arthritis: Evaluating Treatment Effectiveness Among Patients

Abstract

In the real world, how medications are prescribed and taken by patients differs from a patient enrolled in clinical trials. For example, medications may be given to patients with disease severity ranging from mild to very severe, who have comorbidities, and who have variable adherence to the treatment regimen. After a drug is licensed and on the market, comparative effectiveness studies are conducted with real world data to assure that the drugs remain effective when used by real world patients. CorEvitas conducts comparative effectiveness research among cohorts of patients enrolled in the Rheumatoid Arthritis Registry. This poster presents the design of an observational cohort study, including study protocols.